Duratex Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 22-06-2024
- Paid Up Capital ₹ 1.60 M
as on 22-06-2024
- Company Age 64 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.40 M
as on 22-06-2024
- Revenue 17.73%
(FY 2022)
- Profit -168.62%
(FY 2022)
- Ebitda -359.66%
(FY 2022)
- Net Worth -5.25%
(FY 2022)
- Total Assets -23.14%
(FY 2022)
About Duratex Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.60 M.
The company has closed loans amounting to ₹5.40 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Yayati Brahmbhatt, Jayeshbhai Brahmabhatt, and Rashmi Brahmbhatt serve as directors at the Company.
- CIN/LLPIN
U99999GJ1960PTC084300
- Company No.
084300
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jul 1960
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Duratex Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yayati Brahmbhatt  | Director | 25-Jul-2018 | Current |
| Jayeshbhai Brahmabhatt | Director | 15-Jul-2015 | Current |
| Rashmi Brahmbhatt | Director | 30-Dec-2006 | Current |
Financial Performance of Duratex Laboratories.
Duratex Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.73% increase. The company also saw a substantial fall in profitability, with a 168.62% decrease in profit. The company's net worth dipped by a decrease of 5.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Duratex Laboratories?
In 2021, Duratex Laboratories had a promoter holding of 99.94% and a public holding of 0.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Manak Chowk Co- Op. Bank Ltd. Creation Date: 29 Jun 1990 | ₹0.70 M | Satisfied |
The Madhavpura Mercantile Co- Op. Bank Ltd. Creation Date: 19 Mar 1990 | ₹2.70 M | Satisfied |
The Madhavpura Mercantile Co- Op. Bank Ltd. Creation Date: 18 Oct 1989 | ₹2.00 M | Satisfied |
How Many Employees Work at Duratex Laboratories?
Duratex Laboratories has a workforce of 4 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Duratex Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Duratex Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
